Hypothalamic lesions in neuromyelitis optica spectrum disorders: exploring a scoring system based on magnetic resonance imaging

Author(s):  
Wenjing Luo ◽  
Ling Fang ◽  
Zhanhang Wang ◽  
Zifeng Liu ◽  
Jinchi Liao ◽  
...  
2014 ◽  
Vol 20 (10) ◽  
pp. 1407-1408 ◽  
Author(s):  
H Okuma ◽  
K Matsumura ◽  
Y Hatanaka ◽  
F Saito ◽  
M Sonoo

We report a patient with neuromyelitis optica spectrum disorders who presented with sudden onset of sleep as the sole manifestation. Magnetic resonance imaging investigation revealed lesions in the hypothalamus bilaterally, which vanished completely after methylprednisolone pulse therapy.


2020 ◽  
pp. 135245852094998 ◽  
Author(s):  
Diogo Goulart Corrêa ◽  
Fabiana Cavalcanti de Souza Lima ◽  
Daniel da Cruz Bezerra ◽  
Antônio Carlos Coutinho ◽  
Luiz Celso Hygino da Cruz

Neurologic complications are being recognized as important outcomes of coronavirus disease 2019 (COVID-19). Pathogenesis is varied and incompletely understood, and may include neuroinvasion, indirect post-infectious neuroinflammation, and cerebrovascular pathologies. We present a case of COVID-19-related encephalomyeloradiculitis with clinical and magnetic resonance imaging characteristics of neuromyelitis optica spectrum disorders that was associated with anti-aquaporin-4 antibodies. Our case suggests post-infectious autoimmunity as a mechanism in at least a subset of patients with COVID-19-related neurologic disease.


2018 ◽  
Vol 20 (3) ◽  
pp. 142-144 ◽  
Author(s):  
Sarah Kariv ◽  
Kathleen Bateman

A 17-year-old girl presented with intractable vomiting due to area postrema involvement in the first presentation of seronegative neuromyelitis optica (NMO). During the course of her illness, she developed mild hyponatremia, and magnetic resonance imaging revealed abnormalities consistent with the co-occurrence of osmotic demyelination syndrome (ODS). This combination of imaging features is novel, and this case expands the spectrum of brain abnormalities seen in NMO and NMO spectrum disorders. It was suspected that NMO may predispose to ODS by causing astrocyte dysfunction involving aquaporin 4 water channels, which are implicated in both conditions.


2016 ◽  
Vol 22 (10) ◽  
pp. 1371-1375 ◽  
Author(s):  
Akiyuki Uzawa ◽  
Masahiro Mori ◽  
Tomohiko Uchida ◽  
Hiroki Masuda ◽  
Ryohei Ohtani ◽  
...  

Background: Recently, new diagnostic criteria for neuromyelitis optica spectrum disorders (NMOSD) were published. Objective: Our primary aim was to evaluate the usefulness of the new diagnostic criteria in anti-aquaporin 4 (AQP4) antibody-negative cases. Methods: Consecutive 471 patients whose anti-AQP4 antibody was measured at Chiba University were reviewed. Results: Four anti-AQP4 antibody negative-patients, who fulfilled the new diagnostic criteria for NMOSD but not 2006 diagnostic criteria for neuromyelitis optica (NMO), were identified. They showed high cerebrospinal fluid interleukin-6 and glial fibrillary acidic protein levels, an absence of oligoclonal bands and/or cloud-like enhancement on magnetic resonance imaging, which are compatible findings for NMO. Conclusion: The new diagnostic criteria are clinically useful in seronegative NMOSD.


Sign in / Sign up

Export Citation Format

Share Document